Haim Zaltzman, Dan Van Fleet, Axel Magnusson, Tyler Davis, Eric Cho, Chad Jennings, Emily Leong Yu
January 24, 2026
Latham Advises on US$85 Million Financing for SPR Therapeutics
1 min
AI-made summary
- SPR Therapeutics, a private medical device company specializing in pain management, has secured US$85 million in financing, comprising US$25 million in equity and a US$60 million debt facility provided by SLR Capital Partners
- Armentum Partners acted as the company's financial advisor
- Latham represented SLR Capital Partners, with a team led by partners Haim Zaltzman and Dan Van Fleet, and provided additional advice on tax, healthcare regulatory, and security matters.
SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, has announced that it has secured US$85 million in financing including US$25 million in equity and a US$60 million debt facility. The debt facility is provided by SLR Capital Partners. Armentum Partners served as the Company’s financial advisor. Latham represented SLR Capital Partners with a deal team led by partners Haim Zaltzman and Dan Van Fleet, with associates Axel Magnusson and Tyler Davis. Advice was also provided on tax matters by partner Eric Cho; on healthcare regulatory matters by partner Chad Jennings; and on security and intercreditor matters by counsel Emily Leong Yu.~~
Article Author
Haim Zaltzman, Dan Van Fleet, Axel Magnusson, Tyler Davis, Eric Cho, Chad Jennings, Emily Leong Yu
The Sponsor
